Insider Stock Trading History of Gallagher Carol Giltner


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Gallagher Carol Giltner since year 2005. The trader's CIK number is 1329959. At the time of this reporting, Gallagher Carol Giltner is the Director of Atara Biotherapeutics, Inc. . (stock ticker symbol ATRA). See this page for all insider trading activities at Atara Biotherapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Gallagher Carol Giltner since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-02-15 ATRA Atara Biotherapeutics, Inc. Option Ex 2,365 .00 0
2017-02-16 ATRA Atara Biotherapeutics, Inc. Sale 1,183 16.10 19,046
2016-11-16 ATRA Atara Biotherapeutics, Inc. Sale 1,184 19.35 22,910
2016-11-15 ATRA Atara Biotherapeutics, Inc. Option Ex 2,366 .00 0
2016-08-15 ATRA Atara Biotherapeutics, Inc. Option Ex 2,366 .00 0
2016-05-16 ATRA Atara Biotherapeutics, Inc. Option Ex 2,366 .00 0
2016-05-18 ATRA Atara Biotherapeutics, Inc. Sale 1,184 15.96 18,896
2016-02-16 ATRA Atara Biotherapeutics, Inc. Option Ex 2,365 .00 0
2016-02-17 ATRA Atara Biotherapeutics, Inc. Sale 1,183 16.30 19,282
2015-11-16 ATRA Atara Biotherapeutics, Inc. Option Ex 2,366 .00 0
2015-11-17 ATRA Atara Biotherapeutics, Inc. Sale 1,184 31.10 36,822
2015-08-20 ATRA Atara Biotherapeutics, Inc. Sale 5,874 44.40 260,805
2015-08-21 ATRA Atara Biotherapeutics, Inc. Sale 5,874 42.05 247,031
2015-08-24 ATRA Atara Biotherapeutics, Inc. Sale 5,874 40.19 236,076
2015-08-18 ATRA Atara Biotherapeutics, Inc. Sale 5,764 49.38 284,626
2015-08-19 ATRA Atara Biotherapeutics, Inc. Sale 5,875 48.38 284,232
2015-08-17 ATRA Atara Biotherapeutics, Inc. Option Ex 58,521 .00 0
2015-02-18 ATRA Atara Biotherapeutics, Inc. Buy 11,000 18.00 198,000
2014-10-21 ATRA Atara Biotherapeutics, Inc. Buy 18,181 11.00 199,991

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gallagher Carol Giltner (Director of Atara Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.